FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283450363> ?p ?o ?g. }

• W4283450363 endingPage "1382" @default.
• W4283450363 startingPage "1382" @default.
• W4283450363 abstract "Osteoporosis manifest in postmenopausal women is an osteolytic disease characterized by bone loss, leading to increased susceptibility to bone fractures and frailty. The use of complementary therapies to alleviate postmenopausal osteoporosis is fairly widespread among women. The current study examined that Pangasius hypophthalmus fish skin collagen hydrolysates (fsCH) inhibited ovariectomy (OVX)-induced bone loss by conducting inter-comparative experiments for anti-osteoporotic activity among 206–618 mg/kg fsCH, 2 mg/kg isoflavone, 15 mg/kg glycine–proline–hydroxyproline (GPH) tripeptide, and calcium lactate. Surgical estrogen loss of mice for 8 weeks reduced serum 17β-estradiol levels with uterus atrophy, which was ameliorated by orally administering fsCH or isoflavone to mice. Similar to isoflavone, fsCH containing GPH-enhanced bone mineral density reduced levels of cathepsin K and proton-handling proteins, and elevated collagen 1 level in OVX bones. The treatment with fsCH and isoflavone enhanced the serum levels of collagen synthesis-related procollagen type 1 carboxy/amino-terminal propeptides reduced by OVX, whereas serum levels of osteocalcin and alkaline phosphatase, as well as collagen breakdown-related carboxy/amino-terminal telopeptides of type 1 collagen were reduced in OVX mice treated with fsCH, isoflavone, and calcium lactate. The trabecular bones were newly formed in OVX bones treated with isoflavone and fsCH, but not with calcium lactate. However, a low-dose combination of fsCH and calcium lactate had a beneficial synergy effect on postmenopausal osteoporosis. Furthermore, similar to isoflavone, 15–70 μg/mL fsCH, with its constituents of GPH and dipeptides of glycine–proline and proline–hydroxyproline, enhanced osteogenesis through stimulating differentiation, matrix mineralization, and calcium deposition of MC3T3-E1 osteoblasts. Accordingly, the presence of fsCH may encumber estrogen deficiency-induced bone loss through enhancing osteoclastogenic differentiation and matrix collagen synthesis. Therefore, fsCH may be a natural compound retarding postmenopausal osteoporosis and pathological osteoresorptive disorders." @default.
• W4283450363 created "2022-06-26" @default.
• W4283450363 creator A5006097960 @default.
• W4283450363 creator A5023904757 @default.
• W4283450363 creator A5024779519 @default.
• W4283450363 creator A5030230348 @default.
• W4283450363 creator A5049224011 @default.
• W4283450363 creator A5060987352 @default.
• W4283450363 creator A5074722195 @default.
• W4283450363 creator A5076513460 @default.
• W4283450363 creator A5082709148 @default.
• W4283450363 creator A5090679099 @default.
• W4283450363 date "2022-06-10" @default.
• W4283450363 modified "2023-10-16" @default.
• W4283450363 title "Dietary Collagen Hydrolysates Retard Estrogen Deficiency-Induced Bone Loss through Blocking Osteoclastic Activation and Enhancing Osteoblastic Matrix Mineralization" @default.
• W4283450363 cites W1166226317 @default.
• W4283450363 cites W1486738713 @default.
• W4283450363 cites W1557807207 @default.
• W4283450363 cites W1913817918 @default.
• W4283450363 cites W1953418366 @default.
• W4283450363 cites W1965296596 @default.
• W4283450363 cites W1977153578 @default.
• W4283450363 cites W1990353844 @default.
• W4283450363 cites W1991389488 @default.
• W4283450363 cites W1994888871 @default.
• W4283450363 cites W2005746614 @default.
• W4283450363 cites W2010884259 @default.
• W4283450363 cites W2024074948 @default.
• W4283450363 cites W2032523023 @default.
• W4283450363 cites W2038435910 @default.
• W4283450363 cites W2038466470 @default.
• W4283450363 cites W2043202767 @default.
• W4283450363 cites W2048667671 @default.
• W4283450363 cites W2053288021 @default.
• W4283450363 cites W2055763907 @default.
• W4283450363 cites W2061710919 @default.
• W4283450363 cites W2064627397 @default.
• W4283450363 cites W2066264822 @default.
• W4283450363 cites W2072977569 @default.
• W4283450363 cites W2086831062 @default.
• W4283450363 cites W2100376124 @default.
• W4283450363 cites W2100948497 @default.
• W4283450363 cites W2108548612 @default.
• W4283450363 cites W2128057975 @default.
• W4283450363 cites W2159006001 @default.
• W4283450363 cites W2162088346 @default.
• W4283450363 cites W2169022857 @default.
• W4283450363 cites W2559809466 @default.
• W4283450363 cites W2593818584 @default.
• W4283450363 cites W2618566820 @default.
• W4283450363 cites W2647171660 @default.
• W4283450363 cites W2774020342 @default.
• W4283450363 cites W2795115090 @default.
• W4283450363 cites W2983472158 @default.
• W4283450363 cites W2997596905 @default.
• W4283450363 cites W3016503939 @default.
• W4283450363 cites W3035840724 @default.
• W4283450363 cites W3040350801 @default.
• W4283450363 cites W3139514837 @default.
• W4283450363 cites W3152534856 @default.
• W4283450363 cites W3166165759 @default.
• W4283450363 cites W3169194885 @default.
• W4283450363 cites W3175861503 @default.
• W4283450363 cites W3202976142 @default.
• W4283450363 cites W3211582992 @default.
• W4283450363 cites W4210657902 @default.
• W4283450363 cites W4246568810 @default.
• W4283450363 doi "https://doi.org/10.3390/biomedicines10061382" @default.
• W4283450363 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35740404" @default.
• W4283450363 hasPublicationYear "2022" @default.
• W4283450363 type Work @default.
• W4283450363 citedByCount "0" @default.
• W4283450363 crossrefType "journal-article" @default.
• W4283450363 hasAuthorship W4283450363A5006097960 @default.
• W4283450363 hasAuthorship W4283450363A5023904757 @default.
• W4283450363 hasAuthorship W4283450363A5024779519 @default.
• W4283450363 hasAuthorship W4283450363A5030230348 @default.
• W4283450363 hasAuthorship W4283450363A5049224011 @default.
• W4283450363 hasAuthorship W4283450363A5060987352 @default.
• W4283450363 hasAuthorship W4283450363A5074722195 @default.
• W4283450363 hasAuthorship W4283450363A5076513460 @default.
• W4283450363 hasAuthorship W4283450363A5082709148 @default.
• W4283450363 hasAuthorship W4283450363A5090679099 @default.
• W4283450363 hasBestOaLocation W42834503631 @default.
• W4283450363 hasConcept C126322002 @default.
• W4283450363 hasConcept C131075544 @default.
• W4283450363 hasConcept C134018914 @default.
• W4283450363 hasConcept C160160445 @default.
• W4283450363 hasConcept C181199279 @default.
• W4283450363 hasConcept C185592680 @default.
• W4283450363 hasConcept C2776541429 @default.
• W4283450363 hasConcept C2776886416 @default.
• W4283450363 hasConcept C2777083390 @default.
• W4283450363 hasConcept C2777164284 @default.
• W4283450363 hasConcept C2779797417 @default.
• W4283450363 hasConcept C2780644872 @default.
• W4283450363 hasConcept C519063684 @default.
• W4283450363 hasConcept C55493867 @default.

• next